$3.05B
$600,000
0.01% of portfolio
30,000
Q4 2023
Reduced 25.0%
$5.52B
$519,000
0.01% of portfolio
2,850
Q4 2023
New
$597M
$467,000
0.01% of portfolio
42,800
Q4 2022
Reduced 0.28%
$12.1B
$302,000
0.01% of portfolio
2,775
Q1 2024
Reduced 0.18%
$24.4B
$362,000
0.01% of portfolio
3,500
Q3 2023
Reduced 0.14%
$8.43B
$361,000
0.01% of portfolio
2,370
Q2 2023
Reduced 6.88%
$0
$402,000
0.01% of portfolio
9,621
Q2 2024
New
$13.8B
$348,000
0.01% of portfolio
6,579
Q1 2024
Reduced 1.35%
$204B
$511,000
0.01% of portfolio
5,046
Q2 2024
Reduced 0.51%
$84.9B
$321,000
0.01% of portfolio
1,855
Q2 2024
New
$6.46B
$657,000
0.01% of portfolio
5,885
Q4 2023
Added 12.63%
$123B
$298,000
0.01% of portfolio
798
Q2 2024
Added 2.84%
$16.5B
$561,000
0.01% of portfolio
8,750
Q2 2024
Reduced 21.35%
$1.18B
$692,000
0.01% of portfolio
17,900
Q2 2024
Reduced 3.3%
$43.7B
$424,000
0.01% of portfolio
7,861
Q2 2024
Reduced 65.45%
$86.6B
$675,000
0.01% of portfolio
3,375
Q2 2024
Added 2.27%
$268B
$516,000
0.01% of portfolio
3,183
Q2 2024
Reduced 58.26%
$177B
$618,000
0.01% of portfolio
3,180
Q2 2024
Reduced 3.05%
$819B
$604,000
0.01% of portfolio
3,053
Q2 2024
Reduced 46.34%
$1.77B
$397,000
0.01% of portfolio
14,700
Q4 2021
Reduced 21.39%
$205B
$440,000
0.01% of portfolio
1,322
Q2 2024
Added 28.35%
$0
$358,000
0.01% of portfolio
4,641
Q2 2024
New
Apellis Pharmaceuticals Inc (A
-
$0
0.0% of portfolio
-
Q3 2020
New
Live Nation (Lyv) 9.4469 Conv
-
$0
0.0% of portfolio
-
Q4 2022
New
$0
$0
0.0% of portfolio
547,291
Q2 2024
Reduced 0.58%
$5.15B
$233,000
0.0% of portfolio
2,800
Q1 2024
Reduced 0.71%
Guidewire Software Inc (Gwre)
-
$0
0.0% of portfolio
-
Q4 2021
Reduced 68.75%
Stride Inc (Lrn) 18.9109 Con
-
$0
0.0% of portfolio
-
Q3 2021
New
Southwest Airlines CO (Luv)
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 26.67%
Greenbrier Cos Inc (Gbx) 18.
-
$0
0.0% of portfolio
-
Q2 2022
New
Ptc Therapeutics Inc (Ptct)
-
$0
0.0% of portfolio
-
Q2 2022
New
Patrick Industries Inc (Patk)
-
$0
0.0% of portfolio
-
Q4 2022
New
Mirum Pharmaceuticals (Mirm)
-
$0
0.0% of portfolio
-
Q2 2024
New
Exact Sciences (Exas) 8.2076
-
$0
0.0% of portfolio
-
Q2 2020
Reduced 25.0%
Biomarin Pharmaceutical (Bmrn)
-
$0
0.0% of portfolio
-
Q2 2024
Added 16.67%
Array Technologies Inc (Arry)
-
$0
0.0% of portfolio
-
Q1 2024
Added 100.0%
-
$0
0.0% of portfolio
-
Q4 2023
New
Lumentum Holdings (Lite) 10.
-
$0
0.0% of portfolio
-
Q4 2022
Reduced 40.0%
Royal Caribbean Cruises (Rcl)
-
$0
0.0% of portfolio
-
Q3 2023
New
$254M
$36,000
0.0% of portfolio
52,900
Q2 2024
Reduced 3.33%
-
$0
0.0% of portfolio
-
Q2 2023
New
$0
$114,000
0.0% of portfolio
10,000
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 22.54%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.4%
$67.1B
$204,000
0.0% of portfolio
760
Q2 2024
New
-
$0
0.0% of portfolio
-
Q1 2024
New
$1.49B
$252,000
0.0% of portfolio
13,820
Q2 2024
Reduced 1.67%
Net Lease Office Properties
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 85.11%